Stay updated on Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The revision history shows a new Revision: v3.3.4 added and Revision: v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-13T19:19:30.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new Locations section appears with Texas listed as a site, and the separate Texas Locations entry is removed. The page revision tag updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:29:14.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision update: v3.3.1 → v3.3.2; no substantive changes to the study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:48:17.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Publications section wording updated to indicate that these publications are provided voluntarily by the person entering information about the study and are about the results. The revision label changed from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T14:45:42.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Removed the banner that informed users about government funding and potential delays in updates. The notice previously cautioned that the information on the site may not be up to date during funding lapses.
    Difference
    0.3%
    Check dated 2025-11-17T06:55:57.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    No significant changes detected on the Study Details page; the overview, objectives, eligibility criteria, and listed locations remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:20:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page.